Medicine & Life Sciences
Activating Transcription Factor 4
13%
Aldehyde Dehydrogenase
100%
aldehyde dehydrogenase (NAD(P)+)
21%
Aldehydes
5%
Antineoplastic Agents
24%
benzimidazole
36%
Carboxylic Acids
5%
Cell Line
5%
Central Nervous System Diseases
7%
Clinical Trials
10%
Communicable Diseases
13%
Cytoplasmic and Nuclear Receptors
26%
Direction compound
11%
Disease Progression
10%
Drug Delivery Systems
25%
Drug Development
18%
Drug Discovery
52%
Drug Resistance
9%
Epigenomics
25%
Glucose
32%
Hep G2 Cells
20%
Histones
12%
In Vitro Techniques
8%
Inflammation
20%
Inflammatory Bowel Disease 4
5%
Inflammatory Bowel Diseases
24%
Inhibitory Concentration 50
17%
Liver Microsomes
7%
Lysine
12%
Metabolic Brain Diseases
16%
Metabolic Networks and Pathways
12%
Metformin
6%
Methionine
13%
Neoplasms
23%
Obesity
19%
PC-3 Cells
10%
Pharmaceutical Preparations
5%
Phase II Clinical Trials
10%
Phosphorylation
5%
PR-SET Domains
39%
Proteins
37%
Proteolysis
9%
pyrimidine
31%
Structure-Activity Relationship
10%
tetrahydropyrido(4,3-d)pyrimidine
56%
Therapeutics
12%
TIC10 compound
52%
Toxicology
10%
Ubiquitin-Protein Ligases
7%
Chemical Compounds
Antineoplastic Agent
22%
Aromatization
28%
Benzimidazole
26%
Bromodomain-Containing Protein 4 Inhibitor
50%
Dephosphorylation
32%
Disorder
20%
Donor
8%
Drug
40%
Drug Target
14%
Glucose
37%
Histone
19%
Lysine
12%
Metabolic
20%
Metformin
9%
Modification
14%
Molecule
6%
NAD(P)
11%
Physiological Role
5%
Protein
37%
Protein Hydrolysis
7%
Structure-Activity Relationship
22%
Time
9%